Listed

Nanoviricides, Inc.

NNVCNYSECIK 1379006HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2026
Operating income−$2.2m, Q4 FY2026
Net income−$2.2m, Q4 FY2026
Nanoviricides, Inc., income statement, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Revenue$k0.0Revenue, Q1 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure0.0Revenue, Q2 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-02-14, accession 0001410578-24-000048. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-05-15, accession 0001410578-24-000843. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-09-27, accession 0001410578-24-001650. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure0.0Revenue, Q2 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-02-14, accession 0001410578-25-000140. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-15, accession 0001410578-25-001336. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-09-29, accession 0001104659-25-094527. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure0.0Revenue, Q2 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-17, accession 0001104659-26-016476. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001104659-26-061499. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure
Research and development$k1,467Research and development, Q1 FY2024, three months to 2023-09-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure1,574Research and development, Q2 FY2024, three months to 2023-12-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure1,215Research and development, Q3 FY2024, three months to 2024-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure1,182Research and development, Q4 FY2024, three months to 2024-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-09-29, accession 0001104659-25-094527. Derived: 12-month figure less the 9-month figure.Report this figure1,933Research and development, Q1 FY2025, three months to 2024-09-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure1,156Research and development, Q2 FY2025, three months to 2024-12-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure1,282Research and development, Q3 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure1,177Research and development, Q4 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure993Research and development, Q1 FY2026, three months to 2025-09-30$993.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure1,119Research and development, Q2 FY2026, three months to 2025-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure1,286Research and development, Q3 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure1,310Research and development, Q4 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$k(2,032)Operating income, Q1 FY2024, three months to 2023-09-30−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure(2,185)Operating income, Q2 FY2024, three months to 2023-12-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure(1,908)Operating income, Q3 FY2024, three months to 2024-03-31−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure(2,391)Operating income, Q4 FY2024, three months to 2024-06-30−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-29, accession 0001104659-25-094527. Derived: 12-month figure less the 9-month figure.Report this figure(3,168)Operating income, Q1 FY2025, three months to 2024-09-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(2,059)Operating income, Q2 FY2025, three months to 2024-12-31−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure(2,249)Operating income, Q3 FY2025, three months to 2025-03-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(2,116)Operating income, Q4 FY2025, three months to 2025-06-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure(1,797)Operating income, Q1 FY2026, three months to 2025-09-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(2,233)Operating income, Q2 FY2026, three months to 2025-12-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure(2,030)Operating income, Q3 FY2026, three months to 2026-03-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(2,246)Operating income, Q4 FY2026, three months to 2026-06-30−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$k36.5Interest expense, Q1 FY2024, three months to 2023-09-30$36.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure13.3Interest expense, Q2 FY2024, three months to 2023-12-31$13.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-02-14, accession 0001410578-24-000048.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0001410578-24-000843. Derived: 9-month figure less the 6-month figure.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-09-29, accession 0001104659-25-094527. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.1Interest expense, Q2 FY2025, three months to 2024-12-31$149. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001104659-26-061499. Derived: 9-month figure less the 6-month figure.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reported
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(1,969)Net income, Q1 FY2024, three months to 2023-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure(2,115)Net income, Q2 FY2024, three months to 2023-12-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure(1,854)Net income, Q3 FY2024, three months to 2024-03-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure(2,356)Net income, Q4 FY2024, three months to 2024-06-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-29, accession 0001104659-25-094527. Derived: 12-month figure less the 9-month figure.Report this figure(3,127)Net income, Q1 FY2025, three months to 2024-09-30−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(2,027)Net income, Q2 FY2025, three months to 2024-12-31−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(2,217)Net income, Q3 FY2025, three months to 2025-03-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(2,096)Net income, Q4 FY2025, three months to 2025-06-30−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure(1,785)Net income, Q1 FY2026, three months to 2025-09-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(2,221)Net income, Q2 FY2026, three months to 2025-12-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(1,989)Net income, Q3 FY2026, three months to 2026-03-31−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure(2,223)Net income, Q4 FY2026, three months to 2026-06-30−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(0.17)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure(0.18)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure(0.16)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figurenot reported(0.23)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(0.14)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure(0.14)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(0.11)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure(0.09)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figurenot reported
Basic EPS$ per share(0.17)Basic EPS, Q1 FY2024, three months to 2023-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure(0.18)Basic EPS, Q2 FY2024, three months to 2023-12-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure(0.16)Basic EPS, Q3 FY2024, three months to 2024-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figurenot reported(0.23)Basic EPS, Q1 FY2025, three months to 2024-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(0.14)Basic EPS, Q2 FY2025, three months to 2024-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure(0.14)Basic EPS, Q3 FY2025, three months to 2025-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figurenot reported(0.10)Basic EPS, Q1 FY2026, three months to 2025-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(0.11)Basic EPS, Q2 FY2026, three months to 2025-12-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure(0.09)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figurenot reported

Balance sheet

Cash and equivalents$2.8m, FY2026
Shareholders' equity$8.7m, FY2026
Nanoviricides, Inc., balance sheet, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m7.0Cash and equivalents, Q1 FY2024, at 2023-09-30$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure5.2Cash and equivalents, Q2 FY2024, at 2023-12-31$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-14, accession 0001410578-24-000048.Report this figure3.3Cash and equivalents, Q3 FY2024, at 2024-03-31$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001410578-24-000843.Report this figure4.8Cash and equivalents, FY2024, at 2024-06-30$4.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-09-29, accession 0001104659-25-094527.Report this figure3.9Cash and equivalents, Q1 FY2025, at 2024-09-30$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure4.0Cash and equivalents, Q2 FY2025, at 2024-12-31$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure2.5Cash and equivalents, Q3 FY2025, at 2025-03-31$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure1.6Cash and equivalents, FY2025, at 2025-06-30$1.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure1.1Cash and equivalents, Q1 FY2026, at 2025-09-30$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure5.2Cash and equivalents, Q2 FY2026, at 2025-12-31$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure3.2Cash and equivalents, Q3 FY2026, at 2026-03-31$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure2.8Cash and equivalents, FY2026, at 2026-06-30$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure
Current assets$m7.1Current assets, Q1 FY2024, at 2023-09-30$7.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure5.3Current assets, Q2 FY2024, at 2023-12-31$5.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-14, accession 0001410578-24-000048.Report this figure3.5Current assets, Q3 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001410578-24-000843.Report this figure5.0Current assets, FY2024, at 2024-06-30$5.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-09-29, accession 0001104659-25-094527.Report this figure4.0Current assets, Q1 FY2025, at 2024-09-30$4.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure4.1Current assets, Q2 FY2025, at 2024-12-31$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure2.7Current assets, Q3 FY2025, at 2025-03-31$2.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure1.7Current assets, FY2025, at 2025-06-30$1.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure1.3Current assets, Q1 FY2026, at 2025-09-30$1.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure5.3Current assets, Q2 FY2026, at 2025-12-31$5.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure3.4Current assets, Q3 FY2026, at 2026-03-31$3.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure3.2Current assets, FY2026, at 2026-06-30$3.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure
Total assets$m15.4Total assets, Q1 FY2024, at 2023-09-30$15.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure13.4Total assets, Q2 FY2024, at 2023-12-31$13.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-14, accession 0001410578-24-000048.Report this figure11.5Total assets, Q3 FY2024, at 2024-03-31$11.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001410578-24-000843.Report this figure12.8Total assets, FY2024, at 2024-06-30$12.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-09-29, accession 0001104659-25-094527.Report this figure11.7Total assets, Q1 FY2025, at 2024-09-30$11.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure11.6Total assets, Q2 FY2025, at 2024-12-31$11.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure10.0Total assets, Q3 FY2025, at 2025-03-31$10.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure8.8Total assets, FY2025, at 2025-06-30$8.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure8.4Total assets, Q1 FY2026, at 2025-09-30$8.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure12.3Total assets, Q2 FY2026, at 2025-12-31$12.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure10.2Total assets, Q3 FY2026, at 2026-03-31$10.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure9.9Total assets, FY2026, at 2026-06-30$9.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure
Current liabilities$m0.9Current liabilities, Q1 FY2024, at 2023-09-30$948.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure1.0Current liabilities, Q2 FY2024, at 2023-12-31$951.1k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-14, accession 0001410578-24-000048.Report this figure0.8Current liabilities, Q3 FY2024, at 2024-03-31$813.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001410578-24-000843.Report this figure1.4Current liabilities, FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-09-29, accession 0001104659-25-094527.Report this figure1.6Current liabilities, Q1 FY2025, at 2024-09-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure1.2Current liabilities, Q2 FY2025, at 2024-12-31$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure1.2Current liabilities, Q3 FY2025, at 2025-03-31$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure1.3Current liabilities, FY2025, at 2025-06-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure1.2Current liabilities, Q1 FY2026, at 2025-09-30$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure1.2Current liabilities, Q2 FY2026, at 2025-12-31$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure1.1Current liabilities, Q3 FY2026, at 2026-03-31$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure1.2Current liabilities, FY2026, at 2026-06-30$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure
Total liabilities$m2.4Total liabilities, Q1 FY2024, at 2023-09-30$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure1.0Total liabilities, Q2 FY2024, at 2023-12-31$951.1k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-14, accession 0001410578-24-000048.Report this figure0.8Total liabilities, Q3 FY2024, at 2024-03-31$813.3k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001410578-24-000843.Report this figure1.4Total liabilities, FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-09-27, accession 0001410578-24-001650.Report this figure1.6Total liabilities, Q1 FY2025, at 2024-09-30$1.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure1.2Total liabilities, Q2 FY2025, at 2024-12-31$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figurenot reported1.3Total liabilities, FY2025, at 2025-06-30$1.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-09-29, accession 0001104659-25-094527.Report this figure1.2Total liabilities, Q1 FY2026, at 2025-09-30$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure1.2Total liabilities, Q2 FY2026, at 2025-12-31$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure1.1Total liabilities, Q3 FY2026, at 2026-03-31$1.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure1.2Total liabilities, FY2026, at 2026-06-30$1.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m13.0Shareholders' equity, Q1 FY2024, at 2023-09-30$13.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure12.5Shareholders' equity, Q2 FY2024, at 2023-12-31$12.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure10.7Shareholders' equity, Q3 FY2024, at 2024-03-31$10.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure11.5Shareholders' equity, FY2024, at 2024-06-30$11.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure10.1Shareholders' equity, Q1 FY2025, at 2024-09-30$10.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure10.4Shareholders' equity, Q2 FY2025, at 2024-12-31$10.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure8.8Shareholders' equity, Q3 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure7.5Shareholders' equity, FY2025, at 2025-06-30$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure7.2Shareholders' equity, Q1 FY2026, at 2025-09-30$7.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure11.1Shareholders' equity, Q2 FY2026, at 2025-12-31$11.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure9.2Shareholders' equity, Q3 FY2026, at 2026-03-31$9.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure8.7Shareholders' equity, FY2026, at 2026-06-30$8.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure

Cash flow

Operating cash flow−$2.1m, Q4 FY2026
Capital expenditure$1, Q4 FY2026
Nanoviricides, Inc., cash flow, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$k(1,172)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure(1,719)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-14, accession 0001410578-25-000140. Derived: 6-month figure less the 3-month figure.Report this figure(1,944)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001410578-25-001336. Derived: 9-month figure less the 6-month figure.Report this figure(1,481)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-29, accession 0001104659-25-094527. Derived: 12-month figure less the 9-month figure.Report this figure(2,595)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(2,191)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001104659-26-016476. Derived: 6-month figure less the 3-month figure.Report this figure(1,991)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-061499. Derived: 9-month figure less the 6-month figure.Report this figure(1,702)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure(1,594)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(2,050)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001104659-26-016476. Derived: 6-month figure less the 3-month figure.Report this figure(1,931)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-061499. Derived: 9-month figure less the 6-month figure.Report this figure(2,122)Operating cash flow, Q4 FY2026, three months to 2026-06-30−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$k8.3Capital expenditure, Q1 FY2024, three months to 2023-09-30$8.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure5.5Capital expenditure, Q2 FY2024, three months to 2023-12-31$5.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-14, accession 0001410578-25-000140. Derived: 6-month figure less the 3-month figure.Report this figure44.6Capital expenditure, Q3 FY2024, three months to 2024-03-31$44.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001410578-25-001336. Derived: 9-month figure less the 6-month figure.Report this figure98.2Capital expenditure, Q4 FY2024, three months to 2024-06-30$98.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-29, accession 0001104659-25-094527. Derived: 12-month figure less the 9-month figure.Report this figure46.8Capital expenditure, Q1 FY2025, three months to 2024-09-30$46.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001104659-26-016476. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001104659-26-061499. Derived: 9-month figure less the 6-month figure.Report this figure10.2Capital expenditure, Q4 FY2025, three months to 2025-06-30$10.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure84.3Capital expenditure, Q1 FY2026, three months to 2025-09-30$84.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure(0.0)Capital expenditure, Q2 FY2026, three months to 2025-12-31−$1. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001104659-26-016476. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001104659-26-061499. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2026, three months to 2026-06-30$1. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-28, accession 0001104659-26-111390. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)21.61m, Q3 FY2026
Nanoviricides, Inc., shares, quarterly
Line itemUnitQ1 FY20232022-09-30Q2 FY20232022-12-31Q3 FY20232023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)m shares11.6Diluted shares (weighted), Q1 FY2023, three months to 2022-09-3011,592,367 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001410578-23-002484.Report this figure11.6Diluted shares (weighted), Q2 FY2023, three months to 2022-12-3111,610,303 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-14, accession 0001410578-24-000048.Report this figure11.6Diluted shares (weighted), Q3 FY2023, three months to 2023-03-3111,636,041 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001410578-24-000843.Report this figure11.7Diluted shares (weighted), Q1 FY2024, three months to 2023-09-3011,718,791 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001410578-24-001991.Report this figure11.7Diluted shares (weighted), Q2 FY2024, three months to 2023-12-3111,745,906 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-14, accession 0001410578-25-000140.Report this figure11.8Diluted shares (weighted), Q3 FY2024, three months to 2024-03-3111,779,579 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001410578-25-001336.Report this figure13.7Diluted shares (weighted), Q1 FY2025, three months to 2024-09-3013,715,959 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure14.6Diluted shares (weighted), Q2 FY2025, three months to 2024-12-3114,572,042 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure16.0Diluted shares (weighted), Q3 FY2025, three months to 2025-03-3116,026,318 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure17.1Diluted shares (weighted), Q1 FY2026, three months to 2025-09-3017,082,425 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001104659-25-112608.Report this figure19.9Diluted shares (weighted), Q2 FY2026, three months to 2025-12-3119,850,080 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001104659-26-016476.Report this figure21.6Diluted shares (weighted), Q3 FY2026, three months to 2026-03-3121,609,488 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-061499.Report this figure

Shares outstanding: 25.52mShares outstanding, period not labelled, at 2026-09-2825,525,000 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-09-28, accession 0001104659-26-111390.Report this figure at Sep 28, 2026, from the cover of the 10-K filed Sep 28, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.